Bridgeway Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-12,800
Closed -$82K 1454
2018
Q2
$82K Hold
12,800
﹤0.01% 1376
2018
Q1
$89K Hold
12,800
﹤0.01% 1333
2017
Q4
$161K Sell
12,800
-1,500
-10% -$18.3K ﹤0.01% 1296
2017
Q3
$170K Buy
+14,300
New +$212K ﹤0.01% 1302
2015
Q4
Sell
-36,000
Closed -$347K 1473
2015
Q3
$347K Hold
36,000
0.01% 1173
2015
Q2
$417K Hold
36,000
0.01% 1151
2015
Q1
$374K Buy
36,000
+6,100
+20% +$57.1K 0.01% 1198
2014
Q4
$345K Buy
29,900
+18,500
+162% +$183K 0.01% 1186
2014
Q3
$81K Buy
+11,400
New +$79.5K ﹤0.01% 1440

Other funds holding MDXG

Bridgeway Capital Management's MDXG Position: Q3 2018 in Review

Bridgeway Capital Management sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 12,800 shares — an estimated $82K sold.

Bridgeway Capital Management first reported a position in MDXG in Q3 2014 and held it in 9 quarters. The position peaked at $417K in Q2 2015. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

  • Bridgeway Capital Management reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
  • Bridgeway Capital Management sold 12,800 MiMedx Group shares in Q3 2018, an estimated $82K.
  • Bridgeway Capital Management first reported a position in MiMedx Group in Q3 2014 and held it in 9 quarters.
  • Bridgeway Capital Management's MiMedx Group position peaked at $417K in Q2 2015.
  • 186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Bridgeway Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.